MedPAC Proposed Inpatient Update Downplays Effects Of “Unbundling”
This article was originally published in The Gray Sheet
Executive Summary
Per-case unbundling under the Medicare inpatient prospective payment system should not be offset in the fiscal 2003 update, according to the Medicare Payment Advisory Commission
You may also be interested in...
New Technology Productivity Gains Offset Costs, MedPAC Analysts Suggest
The fiscal 2003 adjustment in payments to hospitals providing services for Medicare beneficiaries under the inpatient prospective payment system should not attempt to forecast the potential impact of new medical technology on the system, according to Medicare Payment Advisory Commission analysts
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.